High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.8M
$1,845,145
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
XERS
M
Xeris Biopharma Holdings, Inc.
Pieper Steven
• Officer • See Remarks
Other
2026-03-05
$83,233
|
||||||
| XERS |
Xeris Biopharma Holdings, Inc.
|
Officer • See Remarks
Other
|
2026-03-05 | $83,233 | M | Form 4 |
|
XERS
M
Xeris Biopharma Holdings, Inc.
Pieper Steven
• Officer • See Remarks
Other
2026-03-05
$114,074
|
||||||
| XERS |
Xeris Biopharma Holdings, Inc.
|
Officer • See Remarks
Other
|
2026-03-05 | $114,074 | M | Form 4 |
|
XERS
S
Xeris Biopharma Holdings, Inc.
Hecht Beth
• Officer • See Remarks
10b5-1 Sell
2026-03-02
$706
|
||||||
| XERS |
Xeris Biopharma Holdings, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2026-03-02 | $706 | S | Form 4 |
|
XERS
S
Xeris Biopharma Holdings, Inc.
Hecht Beth
• Officer • See Remarks
10b5-1 Sell
2026-03-02
$103,380
|
||||||
| XERS |
Xeris Biopharma Holdings, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2026-03-02 | $103,380 | S | Form 4 |
|
XERS
S
Xeris Biopharma Holdings, Inc.
Hecht Beth
• Officer • See Remarks
10b5-1 Sell
2026-02-02
$124,147
|
||||||
| XERS |
Xeris Biopharma Holdings, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2026-02-02 | $124,147 | S | Form 4 |
|
XERS
S
Xeris Biopharma Holdings, Inc.
McCulloch Kevin
• Officer • See Remarks
10b5-1 Sell
2026-01-08
$120,000
|
||||||
| XERS |
Xeris Biopharma Holdings, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2026-01-08 | $120,000 | S | Form 4 |
|
XERS
S
Xeris Biopharma Holdings, Inc.
JOHNSON JOHN
• Director
Discretionary SellΔOwn -16.2%
2025-12-19
$977,019
|
||||||
| XERS |
Xeris Biopharma Holdings, Inc.
|
Director
Discretionary SellΔOwn -16.2%
|
2025-12-19 | $977,019 | S | Form 4 |
|
XERS
S
Xeris Biopharma Holdings, Inc.
BORMANN-KENNEDY BARBARA-JEAN ANNE
• Director
10b5-1 Sell
2025-12-12
$106,414
|
||||||
| XERS |
Xeris Biopharma Holdings, Inc.
|
Director
10b5-1 Sell
|
2025-12-12 | $106,414 | S | Form 4 |
|
XERS
S
Xeris Biopharma Holdings, Inc.
Hecht Beth
• Officer • See Remarks
10b5-1 Sell
2025-12-01
$116,781
|
||||||
| XERS |
Xeris Biopharma Holdings, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2025-12-01 | $116,781 | S | Form 4 |
|
XERS
M
Xeris Biopharma Holdings, Inc.
Shannon John Patrick Jr
• Officer • See Remarks
Other
2025-11-14
$135,005
|
||||||
| XERS |
Xeris Biopharma Holdings, Inc.
|
Officer • See Remarks
Other
|
2025-11-14 | $135,005 | M | Form 4 |
|
XERS
M
Xeris Biopharma Holdings, Inc.
Shannon John Patrick Jr
• Officer • See Remarks
Other
2025-11-13
$13,904
|
||||||
| XERS |
Xeris Biopharma Holdings, Inc.
|
Officer • See Remarks
Other
|
2025-11-13 | $13,904 | M | Form 4 |
|
XERS
S
Xeris Biopharma Holdings, Inc.
Shannon John Patrick Jr
• Officer • See Remarks
10b5-1 Sell
2025-11-13
$173,402
|
||||||
| XERS |
Xeris Biopharma Holdings, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2025-11-13 | $173,402 | S | Form 4 |
|
XERS
S
Xeris Biopharma Holdings, Inc.
Hecht Beth
• Officer • See Remarks
10b5-1 Sell
2025-11-11
$123,296
|
||||||
| XERS |
Xeris Biopharma Holdings, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2025-11-11 | $123,296 | S | Form 4 |